{"id":1547,"date":"2020-06-30T06:34:53","date_gmt":"2020-06-30T06:34:53","guid":{"rendered":"http:\/\/isi-iass.org\/home\/?page_id=1547"},"modified":"2021-04-04T06:20:39","modified_gmt":"2021-04-04T06:20:39","slug":"international-covid-19-surveys","status":"publish","type":"page","link":"https:\/\/isi-iass.org\/home\/international-covid-19-surveys\/","title":{"rendered":"Summary of Covid-19 Surveys"},"content":{"rendered":"\n
<\/td>Australia<\/strong><\/td>Brazil (1)<\/strong><\/td>Brazil (2)<\/strong><\/td>Cuba<\/strong><\/td>Italy <\/strong><\/td>Spain<\/strong> <\/td>UK <\/strong><\/td><\/tr>
Study name<\/strong><\/td>Household\n Impacts of COVID-19 Survey<\/td>PNAD COVID19<\/td>EPICOVID19<\/td>National\n Prevalence Survey (seroprevalence)<\/td>Serum-prevalence\n of the SARS-COV2 virus infection<\/td>ENE-COVID19 –\n Estudio Nacional de Sero-Epidemiolog\u00eda de la Infecci\u00f3n por SARS-CoV-2 en\n Espa\u00f1a<\/td>COVID-19\n Infection Survey<\/td><\/tr>
Agency responsible<\/strong><\/td>Australian Bureau of Statistics<\/td>IBGE<\/td>UFPEL – Universidade Federal de\n Pelotas<\/td>Ministerio de Salud P\u00fablica<\/td>Istat + Ministry of Health +\n Italian Red Cross<\/td>INE + Instituto de Salud Carlos\n III<\/td>Office for National Statistics<\/td><\/tr>
Objective<\/strong><\/td>To collect information on:\n concerns about personal health due to the spread of COVID-19; health\n precautions taken in response to COVID-19; job situation; and flu vaccination\n intentions.<\/td>To offer statistics on the\n evolution of the disease and its burden on the population, coupled with some\n statistics on labour force status<\/td>To estimate prevalence of the\n population by immunological status <\/td>Obtain precise estimates of the\n immunological status of the population, monitor the evolution of the\n epidemic, and identify the most significant risk factors for SARS-CoV-2\n infection. <\/td>To understand how many people\n have developed antibodies to Coronavirus, even in the absence of symptoms.<\/td>Obtain precise estimates of the\n immunological status of the population, monitor the evolution of the epidemic<\/td>To estimate prevalence of\n symptomatic and asymptomatic SARS-CoV-2 infection in the general population\n and how this varies over time<\/td><\/tr>
Geographic coverage<\/strong><\/td>National<\/td>National<\/td>133 largest cities in Brazil<\/td>National<\/td>National<\/td>National<\/td>National<\/td><\/tr>
Target population<\/strong><\/td>Persons aged 18 years and over\n in private dwellings (excluding very remote areas)<\/td>Population living in private\n permanent households<\/td>0<\/td>Population living in private\n permanent households<\/td>Resident population in National\n Population Register<\/td>Non-institutionalised resident\n population<\/td>Non-institutionalised resident\n population<\/td><\/tr>
Respondents<\/strong><\/td>Persons aged 18 years and over<\/td>Resident eligible adults in\n households<\/td><\/td><\/td><\/td>Residents<\/td>Adults, adolescents and children\n aged 2 years or older<\/td><\/tr>
Frequency<\/strong><\/td>Every two weeks<\/td>Monthly<\/td>One week<\/td>First two weeks in May<\/td><\/td>Two weeks<\/td>Monthly<\/td><\/tr>
Type of study<\/strong><\/td>Sample survey<\/td>Household sample survey<\/td>Household sample survey, with\n one household member sampled for testing<\/td>Household sample survey with\n seroprevalence study<\/td>Probability sample of\n individuals from National Population Register + Non probabilistic\n serum-prevalence survey in some areas <\/td>Household sample survey<\/td>Household sample survey<\/td><\/tr>
Collection mode(s)<\/strong><\/td>Telephone<\/td>Telephone<\/td>Face-to-face<\/td>Face-to-face<\/td>Face-to-face in testing centers<\/td>Face-to-face in households<\/td>Face-to-face in households<\/td><\/tr>
Evolution in time<\/strong><\/td>Panel survey<\/td>Panel survey, initially\n commissioned for 4 months<\/td>Three waves, separated by three\n weeks<\/td>Expected to be repeated twice\n after first wave<\/td><\/td>Expected to be repeated at least\n three times, separated in time by one week<\/td>Repeated cross-sectional survey,\n for 12 months<\/td><\/tr>
Sample size<\/strong><\/td>1,000 people<\/td>193 thousand households per\n month<\/td>33,250 households per wave<\/td>1,300 households, 4,000\n residents<\/td>150,000 individuals<\/td>36,000 households, 90,000\n individuals. <\/td>20,000 households, 27,500\n individuals per month<\/td><\/tr>
Type of output<\/strong><\/td>National estimates of\n proportions<\/td>Tables, anonymised microdata ,\n weekly estimates for country and five broad regions, monthly estimates for\n country and 27 states<\/td>Estimates of prevalence<\/td>Estimates of the immunological\n status of the population<\/td>Estimates for the size and\n extent of the infection in the population and describe its frequency in\n relation to certain factors such as gender, 6 age classes, 21 regions, 4\n economic activities. <\/td>Estimates of prevalence of\n antibodies to virus for 50 provinces and 2 autonomous cities <\/td>Estimates by age groups (2-4,\n 5-11, 12-17, 18-24, 25-34, 35-44, 45-54, 55-64, 65-74, 75+ years) and\n geographical regions<\/td><\/tr>
Website<\/strong><\/td>https:\/\/www.abs.gov.au\/ausstats\/abs@.nsf\/Lookup\/4940.0main+features11-6%20Apr%202020<\/a><\/td>www.ibge.gov.br<\/a><\/td>http:\/\/portal.ufpel.edu.br\/<\/a><\/td><\/td><\/td>https:\/\/portalcne.isciii.es\/enecovid19\/indexev.html<\/a><\/td>https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/datasets\/coronaviruscovid19infectionsurveydata<\/a><\/td><\/tr>
Contact<\/strong><\/td><\/td>Maria Lucia Vieira\n (marialucia.vieira@ibge.gov.br)<\/td><\/td>Luis Carlos Silva<\/td>Monica Pratesi<\/td>Jos\u00e9 Manual Rodr\u00edguez Poo<\/td><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n
Summary of COVID19 surveys<\/a>Download<\/a><\/div>\n\n\n\n

Additional Resources on Covid-19 Surveillance Surveys<\/h4>\n\n\n\n